Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$0.16 - $0.34 $14,619 - $31,066
-91,372 Reduced 64.65%
49,958 $7,000
Q2 2023

Aug 14, 2023

SELL
$0.24 - $0.37 $3,106 - $4,789
-12,944 Reduced 8.39%
141,330 $36,000
Q1 2023

May 15, 2023

SELL
$0.32 - $0.68 $21,988 - $46,724
-68,713 Reduced 30.81%
154,274 $49,000
Q4 2022

Feb 14, 2023

SELL
$0.35 - $1.26 $46,652 - $167,947
-133,292 Reduced 37.41%
222,987 $93,000
Q3 2022

Nov 14, 2022

BUY
$1.12 - $3.12 $111,384 - $310,284
99,450 Added 38.72%
356,279 $347,000
Q2 2022

Aug 15, 2022

SELL
$2.76 - $7.65 $309,644 - $858,253
-112,190 Reduced 30.4%
256,829 $747,000
Q1 2022

May 16, 2022

BUY
$5.63 - $13.88 $418,843 - $1.03 Million
74,395 Added 25.25%
369,019 $2.78 Million
Q4 2021

Feb 14, 2022

BUY
$13.23 - $26.05 $2.08 Million - $4.09 Million
157,136 Added 114.29%
294,624 $4.12 Million
Q3 2021

Nov 15, 2021

BUY
$25.87 - $46.61 $3.56 Million - $6.41 Million
137,488 New
137,488 $3.56 Million

Others Institutions Holding AMTI

# of Institutions
1
Shares Held
9.42K
Call Options Held
0
Put Options Held
0

About Applied Molecular Transport Inc.


  • Ticker AMTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,900,600
  • Description
  • Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of r...
More about AMTI
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.